Tag: Bria-OTS™

May 28, 2019

BriaCell’s Breakthrough Cancer Treatment Technology Featured in BNN Bloomberg

BriaCell Therapeutics (TSXV:BCT) (OTC:BCTXF) was recently featured in a sponsored article published in BNN Bloomberg.
May 28, 2019

BriaCell’s Novel Technology and Clinical Data Published at the 2019 American Society of Clinical Oncology (ASCO) Annual Meeting

BriaCell Therapeutics Corp. ("BriaCell" or the "Company") (TSXV:BCT) (OTCQB:BCTXF), a clinical-stage biotechnology company specializing in targeted immunotherapy for advanced breast...
May 24, 2019

BriaCell’s Immunotherapy Technology Featured in The Financial Post

BriaCell Therapeutics (TSXV:BCT) (OTCQB:BCTXF) has been featured in a paid advertisement published in The Financial Post.
May 13, 2019

BriaCell Approves New Board of Directors and Chairman at Annual and Special Meeting of Shareholders

BriaCell Therapeutics Corp. (TSX:BCT, OTCQB:BCTXF), a clinical-stage biotechnology company specializing in targeted immunotherapy for advanced breast cancer, today announced that...
April 23, 2019

BriaCell Announces Publication at American Society of Clinical Oncology (ASCO) Meeting and Presentation at Precision Breast Cancer Summit in Boston

BriaCell Therapeutics Corp. ("BriaCell" or the "Company") (TSX-V:BCT) (OTCQB:BCTXF), a clinical-stage biotechnology company specializing in targeted immunotherapy for advanced breast...
April 3, 2019

BriaCell’s Lead Candidate Combined With KEYTRUDA®: Strong Evidence of Rapid Additive or Synergistic Anti-Tumor Activity

BriaCell Therapeutics Corp. (TSX:BCT, OTCQB:BCTXF), a clinical-stage biotechnology company specializing in targeted immunotherapy for advanced breast cancer, today announced early...
April 2, 2019

BriaCell Announces Clinical Trial Collaboration Agreement with Incyte

BriaCell Therapeutics Corp. ("BriaCell" or the "Company") (TSXV:BCT) (OTCQB:BCTXF), a clinical-stage biotechnology company specializing in targeted immunotherapy for advanced breast...